Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.
#YonhapInfomax #SamsungBioepis #ObesityTreatment #G2GBio #DrugDeliveryTechnology #Semaglutide #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=110037
Samsung Bioepis, EpisNexLab Partner with G2GBio to Develop Obesity Treatment
Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.
Hims & Hers Health shares surge 39% on partnership with Novo Nordisk to distribute Wegovy obesity treatment, ending legal disputes over compounded drug sales while securing official distribution channel and eliminating regulatory uncertainties for the telehealth platform
#YonhapInfomax #HimsAndHers #NovoNordisk #Wegovy #ObesityTreatment #TelehealthPartnership #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=109028
'From Foes to Allies' - Hims & Hers Stock Soars on Novo Nordisk Partnership
Hims & Hers Health shares surge 39% on partnership with Novo Nordisk to distribute Wegovy obesity treatment, ending legal disputes over compounded drug sales while securing official distribution channel and eliminating regulatory uncertainties for the telehealth platform
Daewoong Pharmaceutical Targets Global Market with ‘Obesity Patch’
Daewoong Pharmaceutical has signed a global licensing deal for microneedle-based obesity patches, aiming to capture a share of the rapidly expanding $200 billion global obesity treatment market by 2030.
Are Popular Weight-Loss Medicines Safe for Long-Term Use in India?
This guide explores the long-term safety of commonly used weight-loss medicines in India, covering effectiveness, side effects, and when medical monitoring is essential.
https://mrmedonlinepharmacy.blogspot.com/2026/01/are-popular-weight-loss-medicines-safe.html
#WeightLossMedicines #IndiaHealth #ObesityTreatment #HealthyWeight
Looking for bariatric surgery in India? MyCure Pathway offers expert surgeons, advanced hospitals, affordable packages & complete care. Start your weight loss journey today!
Visit -
https://mycurepathway.com/bariatric-surgery-in-india/#BariatricSurgeryInIndia #WeightLossSurgery #MyCurePathway #ObesityTreatment #HealthyLife
Bariatric Surgery in India | Affordable Weight Loss Surgery
Get safe and affordable bariatric surgery in India from top hospitals and experienced surgeons. Achieve lasting weight loss with advanced treatment options.
Which Is the Safest GLP-1 Injection for Weight Loss in India?
Compare GLP-1 injection safety in India (Wegovy, Ozempic, Mounjaro). Understand common side effects & who should avoid treatment. Consult your specialist today.
https://joyrulez.com/blogs/206258/Which-Is-the-Safest-GLP-1-Injection-for-Weight-Loss
#GLP1India #WeightLossInjection #Semaglutide #OzempicSafety #ObesityTreatment #IndiaHealth
Which Is the Safest GLP-1 Injection for Weight Loss in India? |...
Losing weight is not only about looking better but also about feeling healthier, stronger, and more confident. For many people, diet and exercise alone do not always lead to lasting results. That is where a new class of medications called GLP-1 receptor agonists has become a game changer.
These...
Can Mounjaro Really Help You Lose Weight Fast? What Science and Doctors Say
Uncover the science behind Mounjaro (tirzepatide), the dual-action injection. Clinical trials show significant, rapid weight loss. See what experts say about its safety, efficacy, and future.
https://www.hasster.com/blogs/250829/Can-Mounjaro-Really-Help-You-Lose-Weight-Fast-What-Science
#MounjaroWeightLoss #Tirzepatide #FastWeightLoss #ObesityTreatment #GLP1
Metsera Shares Surge 60% on News of Pfizer Acquisition
Metsera shares soared nearly 60% after announcing a potential $7.3 billion acquisition by Pfizer, reflecting strong investor optimism in the obesity drug sector.
D&D Pharmatech Shares Surge to Daily Limit on Expectations of Partner Metsera’s Acquisition
D&D Pharmatech shares hit the daily upper limit after news that partner Metsera is in talks for a $7.3 billion acquisition by Pfizer, boosting market optimism.
Chong Kun Dang and Novo Nordisk Korea have signed a co-promotion agreement for Wegovy, an obesity drug that led South Korea’s prescription sales in Q2, aiming to expand the domestic obesity treatment market.
#YonhapInfomax #ChongKunDang #NovoNordisk #Wegovy #ObesityTreatment #SalesRanking #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=82375
Chong Kun Dang Signs Co-Promotion Deal with Novo Nordisk Korea for Obesity Drug Wegovy
Chong Kun Dang and Novo Nordisk Korea have signed a co-promotion agreement for Wegovy, an obesity drug that led South Korea’s prescription sales in Q2, aiming to expand the domestic obesity treatment market.
Yonhap Infomax News
MrMed : Online Pharmacy
Mycure Pathway